Publicaciones (25) Publicaciones de Jaime Espinós Jiménez

2024

  1. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer

    Seminars in Oncology Nursing, Vol. 40, Núm. 1

  2. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

    Clinical and Translational Oncology

2023

  1. Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies

    Biomedicines, Vol. 11, Núm. 2

2020

  1. Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

    Gynecologic Oncology Reports, Vol. 33

  2. Immune Checkpoint Inhibitors for the Therapy of Thymoma

    JTO Clinical and Research Reports, Vol. 1, Núm. 1

2019

  1. Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach

    British Journal of Clinical Pharmacology, Vol. 85, Núm. 8, pp. 1670-1683

2018

  1. Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience

    Breast Journal, Vol. 24, Núm. 4, pp. 473-479

2017

  1. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer

    International Journal of Gynecological Cancer, Vol. 26, Núm. 6, pp. 1162-1168

2015

  1. 37th Annual San Antonio Breast Cancer Symposium. Summary of the most important translational and clinical contributions

    Revista de Senologia y Patologia Mamaria

  2. Safety and efficacy of temsirolimus under compassionate use in heavily pretreated patients with poor-prognosis solid tumors

    Minerva Chirurgica

2014

  1. MYH polyposis syndrome: Clinical findings, genetics issues and management

    Clinical and Translational Oncology, Vol. 16, Núm. 8, pp. 675-679

2013

  1. Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: A retrospective cohort study

    Journal of Neuro-Oncology

2011

  1. A new rapid desensitization protocol for chemotherapy agents

    Journal of Investigational Allergology and Clinical Immunology, Vol. 21, Núm. 2, pp. 108-112

2010

  1. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

  2. Hepatic breast cancer dissemination after an iatrogenic hepatic laceration during talc pleurodesis: A case report

    International Archives of Medicine, Vol. 3, Núm. 1

  3. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465

2009

  1. Pregnancy associated breast cancer

    European Journal of Surgical Oncology, Vol. 35, Núm. 2, pp. 215-218

  2. Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 765-766

2008

  1. Hormonal therapy in breast cancer

    Revista de medicina de la Universidad de Navarra, Vol. 52, Núm. 1, pp. 40-48